Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy

NCT03043027 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT03043027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03043027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy
Lead sponsor
Northwell Health
Phase
Phase 3
Overall status
Withdrawn
Start date
August 8, 2017
Completion date
August 8, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain, renal calculi